Tuesday, November 22, 2016

Partnerships in Clinical Trials Europe 2016...in pictures

Last week over 1000 of the leading figures in clinical trials gathered in Vienna for Partnerships in Clinical Trials Europe. As well as dozens of thought-provoking talks and hundreds of meetings, there was samba dancing, an Olympic gold medallist, fine dining and a lifetime acheivement award. But we're getting ahead of ourselves; let's start at the beginning...

Before the main conference started, workshops explored five of the hottest topics and biggest challenges in clinical trials today, before the Covance welcome casino kicked-off the social side of things.

The next day registration opened bright and early

The event producers welcomed everyone in the opening plenary, before Matthew Zachary, Founder of StupidCancer, started the agenda with a few musical numbers around patient-centricity.

Meanwhile the exhibition hall was up and running, with over 450 companies represented at the conference.

Over the two days of the main agenda, patient-centricity and technology were key topics that came up time and time again across the eight streams.

Meetings continued on the exhibition hall throughout the week.

Tweets flooded in on social media and throughout day 1 #PCTrials was trending on Twitter.

The coveted Lifetime Achievement Award, sponsored by mdlifesciences, was awarded at the end of a busy first day to Jean Edwards, Procurement Director, Europe, Canada & Japan at Eli Lilly. 

From one inspirational speaker to another, five-time GB Olympic gold medallist Sir Steve Redgrave had been signing books for a long queue of fans before speaking on how he overcame a diabetes diagnosis to claim his fifth gold medal in 2000.

As the audience filtered out of the hall, we were met with samba drums and Brazilian dancers at the PCT party. Caipirinhas in a wintry Vienna won't soon be forgotten.

After enjoying a day in the lounge, our VIPs headed to the highest restaurant in Vienna, with amazing views over the city and stunning food on the table.

No comments: